These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 11555849

  • 1. Monitoring of treatment success in patients with acromegaly: the value of serum insulin-like growth factor binding protein-3 and serum leptin measurements in comparison to plasma insulin-like growth factor I determination.
    Páramo C, Fluiters E, de la Fuente J, Andrade A, García-Mayor RV.
    Metabolism; 2001 Sep; 50(9):1117-21. PubMed ID: 11555849
    [Abstract] [Full Text] [Related]

  • 2. Diagnostic value of serum IGF-I and IGFBP-3 in growth hormone disorders in adults.
    Kim HJ, Kwon SH, Kim SW, Park DJ, Shin CS, Park KS, Kim SY, Cho BY, Lee HK.
    Horm Res; 2001 Sep; 56(3-4):117-23. PubMed ID: 11847474
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Diagnostic value of the acid-labile subunit in acromegaly: evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3.
    Arosio M, Garrone S, Bruzzi P, Faglia G, Minuto F, Barreca A.
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1091-8. PubMed ID: 11238491
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Serum IGF-I and IGFBP-3 levels for the assessment of disease activity of acromegaly.
    Chen HS, Lin HD.
    J Endocrinol Invest; 1999 Feb; 22(2):98-103. PubMed ID: 10195375
    [Abstract] [Full Text] [Related]

  • 7. A comparison of different methods for diagnosing acromegaly.
    Stoffel-Wagner B, Springer W, Bidlingmaier F, Klingmüller D.
    Clin Endocrinol (Oxf); 1997 May; 46(5):531-7. PubMed ID: 9231047
    [Abstract] [Full Text] [Related]

  • 8. The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients.
    Juul A, Main K, Blum WF, Lindholm J, Ranke MB, Skakkebaek NE.
    Clin Endocrinol (Oxf); 1994 Jul; 41(1):85-93. PubMed ID: 7519529
    [Abstract] [Full Text] [Related]

  • 9. High levels of 150-kDa insulin-like growth factor binding protein three ternary complex in patients with acromegaly and the effect of pegvisomant-induced serum IGF-I normalization.
    Parkinson C, Flyvbjerg A, Trainer PJ.
    Growth Horm IGF Res; 2004 Feb; 14(1):59-65. PubMed ID: 14700556
    [Abstract] [Full Text] [Related]

  • 10. The role of IGF binding protein-3 as a parameter of activity in acromegalic patients.
    Halperin I, Casamitjana R, Flores L, Fernandez-Balsells M, Vilardell E.
    Eur J Endocrinol; 1999 Aug; 141(2):145-8. PubMed ID: 10427158
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly.
    Freda PU, Post KD, Powell JS, Wardlaw SL.
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3808-16. PubMed ID: 9814451
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A Bayesian Approach to Diagnose Growth Hormone Deficiency in Children: Insulin-Like Growth Factor Type 1 Is Valuable for Screening and IGF-Binding Protein Type 3 for Confirmation.
    Inoue-Lima TH, Vasques GA, Nakaguma M, Brito LP, Mendonça BB, Arnhold IJP, Jorge AAL.
    Horm Res Paediatr; 2020 Nov; 93(3):197-205. PubMed ID: 32799208
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Insulin-like growth factor binding protein-3 levels during early and late follow-up after surgery in acromegalic patients.
    Charalampaki P, Hildebrandt G, Schaeffer HJ, Schönau E, Klug N.
    Exp Clin Endocrinol Diabetes; 1998 Nov; 106(2):130-4. PubMed ID: 9628244
    [Abstract] [Full Text] [Related]

  • 17. Paradoxical elevations in serum IGF-II and IGF binding protein-2 in acromegaly: insights into the regulation of these peptides.
    Renehan AG, Toogood AA, Ryder WD, Jones J, Potten CS, O'Dwyer ST, Shalet SM.
    Clin Endocrinol (Oxf); 2001 Oct; 55(4):469-75. PubMed ID: 11678829
    [Abstract] [Full Text] [Related]

  • 18. Assessment of disease activity in treated acromegalic patients using a sensitive GH assay: should we achieve strict normal GH levels for a biochemical cure?
    Costa AC, Rossi A, Martinelli CE, Machado HR, Moreira AC.
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3142-7. PubMed ID: 12107214
    [Abstract] [Full Text] [Related]

  • 19. Serum insulin-like growth factor (IGF)-I, IGF binding protein (IGFBP)-3, leptin concentrations and insulin resistance in benign and malignant epithelial ovarian tumors in postmenopausal women.
    Serin IS, Tanriverdi F, Yilmaz MO, Ozcelik B, Unluhizarci K.
    Gynecol Endocrinol; 2008 Mar; 24(3):117-21. PubMed ID: 18335323
    [Abstract] [Full Text] [Related]

  • 20. Serum levels of leptin, insulin-like growth factor-I and insulin-like growth factor binding protein-3 in women with pre-eclampsia, and their relationship to insulin resistance.
    Kocyigit Y, Bayhan G, Atamer A, Atamer Y.
    Gynecol Endocrinol; 2004 Jun; 18(6):341-8. PubMed ID: 15497497
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.